Last 5,065
Change Today 0.00 / 0.00%
Volume 0.0
EVGN On Other Exchanges
New York
Tel Aviv
As of 10:24 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

evogene ltd (EVGN) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/1/14 - $6,995
52 Week Low
07/30/13 - $4,046
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for EVOGENE LTD (EVGN)

Related News

No related news articles were found.

evogene ltd (EVGN) Related Businessweek News

No Related Businessweek News Found

evogene ltd (EVGN) Details

Evogene Ltd. operates as a plant genomics company that uses a technology infrastructure to enhance seed traits underlying crop productivity. The company operates in two segments, Evogene and Evofuel. The Evogene segment develops technologies to enhance plant performance through seed traits and ag-chemicals. Its seed trait operation utilizes to address yield and abiotic stress and biotic stress traits through the genetic modification or breeding of seeds; and ag-chemical operations utilize to develop novel crop protection and crop enhancement products, including herbicides. The Evofuel segment develops species of the castor bean plant for second generation feedstock for use in the alternative fuel industry, specifically biodiesel and biojet. Its products focus on various crops comprising corn, soybean, wheat, rice, and cotton. Evogene Ltd. has strategic collaborations with agricultural companies primarily to develop traits for yield and abiotic stress tolerance, such as enhanced tolerance to drought, heat, and salinity; and biotic stress resistance, including resistance to disease, pests, and insects. The company was founded in 1999 and is headquartered in Rehovot, Israel.

192 Employees
Last Reported Date: 04/8/14
Founded in 1999

evogene ltd (EVGN) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: $749.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $352.0K
Chief Technology Officer and Executive Vice P...
Total Annual Compensation: $304.0K
Executive Vice President of Technology Infras...
Total Annual Compensation: $303.0K
Executive Vice President of Strategy and Busi...
Total Annual Compensation: $406.0K
Compensation as of Fiscal Year 2013.

evogene ltd (EVGN) Key Developments

Evogene Ltd. Appoints Eyal Emmanuel as Executive Vice President R&D, Crop Protection

Evogene Ltd. appointed Dr. Eyal Emmanuel to serve as Executive Vice President R&D, Crop Protection. The appointment was effective immediately. Dr. Eyal Emmanuel joined Evogene in May 2006, and since that time has held various R&D management positions at the company, most recently as Vice President R&D of the company's Ag-Chemicals division. Prior to joining Evogene, Dr. Emmanuel served as a researcher at Life Science Research Israel, Israel's premier life sciences research center.

Evogene Ltd. Approves Amendments to its Articles of Association

Evogene Ltd. at its Annual General Meeting of shareholders, held on May 14, 2014, approved the amendment of articles 19 and 21 of the company's articles of association, eliminating the staggered Board" mechanism, and providing for the re-election of all directors (other than external directors) on an annual basis.

Evogene Ltd. Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2014

Evogene Ltd. announced unaudited consolidated financial results for the first quarter ended March 31, 2014. For the quarter, the company reported total revenues of $3,857,000 against $4,616,000 a year ago. Operating loss was $2,625,000 against $582,000 a year ago. Net and comprehensive loss was $2,337,000 against $481,000 a year ago. Basic and diluted loss per share was $0.09 against $0.03 a year ago. Net cash used in operating activities was $3,223,000 against $2,787,000 a year ago. Purchase of property, plant and equipment was $303,000 against $149,000 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVGN:IT 5,065.00 0.00

EVGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EVGN.
View Industry Companies

Industry Analysis


Industry Average

Valuation EVGN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOGENE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at